Pacific Biosciences/PACB

$5.19

-6.14%
-
1D1W1MYTD1YMAX

About Pacific Biosciences

Pacific Biosciences of California, Inc. is a life science technology company. The Company designs, develops and manufactures advanced sequencing solutions to help scientists and clinical researchers resolve genetically complex problems. The Company has developed Single Molecule, Real-Time (SMRT) technology, which accurately detects the nucleotide sequence and epigenetic status of individual deoxyribonucleic acid (DNA) molecules. The Company’s products include Revio, Sequel, Sequel II and Sequel IIe instruments that conduct, monitor, and analyze single-molecule biochemical reactions in real time. The instruments use extremely sensitive imaging systems to collect the light pulses emitted by fluorescent reagents allowing the observation of biological processes. Once sequencing is started, the real-time data is delivered to the system’s primary analysis pipeline, which outputs base identity and quality values.

Ticker

PACB

Sector

Healthcare

Trading on

NASDAQ

Industry

Medical Equipment & Supplies

CEO

Christian Henry

Employees

796

Headquarters

Menlo park, United States

PACB Metrics

BasicAdvanced
$1.48B
Market cap
-
P/E ratio
-$1.21
EPS
1.87
Beta
-
Dividend rate

What the Analysts think about PACB

Analyst Ratings

Majority rating from 15 analysts.
Buy

Price Targets

Average projection from 13 analysts.
115.61% upside
High $20.00
Low $6.50
$5.19
Current price
$11.19
Average price target

PACB Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-140.65% profit margin
QuarterlyAnnual
Q4 23
QoQ growth
Revenue
$58.3M
4.86%
Net income
$-82M
22.75%
Profit margin
-140.65%
17.07%

PACB Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 8.7%
QuarterlyAnnual
Q1 23
Q2 23
Q3 23
Q4 23
Q1 24
Actual
-$0.36
-$0.28
-$0.26
-$0.31
-
Expected
-$0.33
-$0.32
-$0.33
-$0.29
-$0.27
Surprise
8.27%
-12.67%
-20.76%
8.7%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

Buy or sell Pacific Biosciences stock

Buy or sell Pacific Biosciences stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing